Follow
Clinical Oncology
Clinical oncology consists of three primary disciplines: medical oncology (the treatment of cancer with medicine, eg. chemotherapy), surgical oncology (the surgical aspects of cancer including biopsy, staging, and surgical resection of tumors), and radiation oncology (the treatment of cancer with therapeutic radiation).
What's Popular in Clinical Oncology
-
JUN 27, 2025Clinical & Molecular DX
When tumors grow, they can shed DNA that is detectable in the blood.Written By: Carmen LeitchJAN 19, 2025Clinical & Molecular DX
When cancer is detected earlier, it can improve outcomes for patients. Liquid biopsies are one way to improve cancer det ...Written By: Carmen LeitchJUL 02, 2024Clinical & Molecular DX
New research has shown that a prostate cancer detection method using positron-emitting tomography (PET) and computerized ...Written By: Carmen LeitchJUN 19, 2024Genetics & Genomics
Lung cancer is a leading cause of cancer-related deaths. There are two primary types of lung cancer: non-small cell lung ...Written By: Carmen LeitchJUN 03, 2024Clinical & Molecular DX
Many people have heard of the BRCA1 and BRCA2 genes because of their association with breast cancer. But scientist have ...Written By: Carmen Leitch
JUN 27, 2025
Clinical & Molecular DX
When tumors grow, they can shed DNA that is detectable in the blood.
Written By:
Carmen Leitch
JAN 19, 2025
Clinical & Molecular DX
When cancer is detected earlier, it can improve outcomes for patients. Liquid biopsies are one way to improve cancer det
...
Written By:
Carmen Leitch
JUL 02, 2024
Clinical & Molecular DX
New research has shown that a prostate cancer detection method using positron-emitting tomography (PET) and computerized
...
Written By:
Carmen Leitch
JUN 19, 2024
Genetics & Genomics
Lung cancer is a leading cause of cancer-related deaths. There are two primary types of lung cancer: non-small cell lung
...
Written By:
Carmen Leitch
JUN 03, 2024
Clinical & Molecular DX
Many people have heard of the BRCA1 and BRCA2 genes because of their association with breast cancer. But scientist have
...
Written By:
Carmen Leitch
MAY 31, 2024
Clinical & Molecular DX
Around 150,000 Americans are diagnosed with colon cancer every year, and it is the second-leading cause of cancer death.
Written By:
Carmen Leitch
APR 19, 2024
Genetics & Genomics
There are some genes that can promote cancer; they are sometimes called oncogenes, and in tumor cells, mutations are oft
...
Written By:
Carmen Leitch
APR 16, 2024
Clinical & Molecular DX
Diet is known to have an influence on the incidence of obesity, and obesity has been associated with a greater incidence
...
Written By:
Carmen Leitch
APR 11, 2024
Clinical & Molecular DX
Anyone who needs an unusual mole on their skin checked out may soon get to skip a surgical biopsy, and instead have a vi
...
Written By:
Carmen Leitch
-
APR 02, 2024 | 8:00 AM
Circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) have each gained attention as promising liquid biopsy markers, offering molecular insights into cancer progression, overall s...MAR 26, 2024 | 7:00 PMC.E. CREDITS
The implementation of a preemptive pharmacogenomics (PGx) program in a hospital setting requires a multidisciplinary approach to ensure seamless integration of each stage of the process for...Speaker: Steven Melnick. Ph.D., M.D. , Dr. David Mancuso, Pharm.D. CPh , MSPMSponsored By: Thermo Fisher ScientificMAR 26, 2024 | 8:00 AMC.E. CREDITS
The implementation of a preemptive pharmacogenomics (PGx) program in a hospital setting requires a multidisciplinary approach to ensure seamless integration of each stage of the process for...Speaker: Steven Melnick. Ph.D., M.D. , Dr. David Mancuso, Pharm.D. CPh , MSPMSponsored By: Thermo Fisher ScientificJAN 16, 2024 | 8:00 AM
The clinical interpretation of genetic testing results remains one of the most significant hurdles in effectively applying genomics in modern medicine. Errors in variant interpretation, whet...DEC 07, 2023 | 10:00 AMC.E. CREDITS
Lateral flow assay applications have become increasingly diverse in a post-pandemic world, and the areas of infectious disease and oncology continue to be at the forefront. In both areas, th...
APR 02, 2024 | 8:00 AM
Circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) have each gained attention as promising liquid biopsy markers, offering molecular insights into cancer progression, overall s...
MAR 26, 2024 | 7:00 PM
C.E. CREDITS
The implementation of a preemptive pharmacogenomics (PGx) program in a hospital setting requires a multidisciplinary approach to ensure seamless integration of each stage of the process for...
Speaker:
Steven Melnick. Ph.D., M.D.
, Dr. David Mancuso, Pharm.D. CPh , MSPM
Sponsored By: Thermo Fisher Scientific
MAR 26, 2024 | 8:00 AM
C.E. CREDITS
The implementation of a preemptive pharmacogenomics (PGx) program in a hospital setting requires a multidisciplinary approach to ensure seamless integration of each stage of the process for...
Speaker:
Steven Melnick. Ph.D., M.D.
, Dr. David Mancuso, Pharm.D. CPh , MSPM
Sponsored By: Thermo Fisher Scientific
JAN 16, 2024 | 8:00 AM
The clinical interpretation of genetic testing results remains one of the most significant hurdles in effectively applying genomics in modern medicine. Errors in variant interpretation, whet...
DEC 07, 2023 | 10:00 AM
C.E. CREDITS
Lateral flow assay applications have become increasingly diverse in a post-pandemic world, and the areas of infectious disease and oncology continue to be at the forefront. In both areas, th...
DEC 07, 2023 | 8:00 AM
As the vast landscape of genetic oncology continues to expand, the ability to understand and utilize the full potential of this rich data becomes increasingly challenging. As a result, resea...
NOV 29, 2023 | 9:00 AM
Tumor genomic profiling can be complicated, especially for diseases that commonly have multiple different genomic biomarkers of interest, such as non-small cell lung cancer (NSCLC) and color...
NOV 14, 2023 | 9:00 PM
Spheroids and organoids, two examples of 3D cell culture models, have become invaluable tools to study the processes that dictate behavior of tissues under physiological and pathological con...
NOV 01, 2023 | 8:00 AM
To bring your cutting-edge cell and gene therapies to the patients that need them as quickly as possible, you need access to the most knowledgeable scientists, innovative technologies, metho...
-
Labroots is excited to announce the 16th Annual Event in the Clinical Diagnostics & Research Virtual Event Series taking place on November 12th, 2025! This event will again bring togethe...
Labroots is pleased to announce the 5 th annual event in the Immuno-Oncology Virtual Event Series taking place on April 29th, 2026. Immuno-Oncology is at the forefront of groundbreaking rese...
Labroots is excited to bring leading academia and industry experts, research scholars, healthcare and medical professionals, clinicians, oncologists, and top scientists under one virtual roo...
Labroots is excited to announce the 17th Annual Event in the Clinical Diagnostics & Research Virtual Event Series taking place on November 11th, 2026! This event will again bring togethe...OCT 01, 2025 | 5:30 AM PDTC.E. CREDITS
Labroots is excited to bring leading academia and industry experts, research scholars, healthcare and medical professionals, clinicians, oncologists, and top scientists under one virtual roo...
Labroots is excited to announce the 16th Annual Event in the Clinical Diagnostics & Research Virtual Event Series taking place on November 12th, 2025! This event will again bring togethe...
Labroots is pleased to announce the 5 th annual event in the Immuno-Oncology Virtual Event Series taking place on April 29th, 2026. Immuno-Oncology is at the forefront of groundbreaking rese...
Labroots is excited to bring leading academia and industry experts, research scholars, healthcare and medical professionals, clinicians, oncologists, and top scientists under one virtual roo...
Labroots is excited to announce the 17th Annual Event in the Clinical Diagnostics & Research Virtual Event Series taking place on November 11th, 2026! This event will again bring togethe...
OCT 01, 2025
| 5:30 AM PDT
C.E. CREDITS
Labroots is excited to bring leading academia and industry experts, research scholars, healthcare and medical professionals, clinicians, oncologists, and top scientists under one virtual roo...
OCT 27, 2025
C.E. CREDITS
Stago EdVantage Virtual University is an educational platform that demystifies hemostasis testing with on-demand webinars and a virtual exhibit hall that ......
APR 30, 2025
| 5:30 AM PDT
C.E. CREDITS
Labroots is pleased to announce the 4th annual event in the Immuno-Oncology Virtual Event Series taking place on April 30th, 2025. Immuno-Oncology is at the forefront of groundbreaking resea...
NOV 13, 2024
| 6:00 AM PST
C.E. CREDITS
Labroots is excited to announce the 15th Annual Event in the Clinical Diagnostics & Research Virtual Event Series! This event will again bring together clinicians, researchers, medical e...
OCT 02, 2024
| 7:00 AM PDT
C.E. CREDITS
Labroots is excited to bring leading academia and industry experts, research scholars, healthcare and medical professionals, clinicians, oncologists, and top scientists under one virtual roo...